Letter to the Editor Reply
Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease”
Tuncay Güzel 1
, Adem Aktan 2
, Raif Kılıç 3
, Bayram Arslan 4
, Muhammed Demir 5
, Mehmet Özbek 5
, Faruk Ertaş 5
, Adem Aktan 2
, Raif Kılıç 3
, Bayram Arslan 4
, Muhammed Demir 5
, Mehmet Özbek 5
, Faruk Ertaş 5
1Department of Cardiology, Health Science University, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Türkiye
2Department of Cardiology, Mardin Training and Research Hospital, Mardin, Türkiye
3Department of Cardiology, Diyarlife Hospital, Diyarbakır, Türkiye
4Department of Cardiology, Ergani State Hospital, Diyarbakır, Türkiye
5Department of Cardiology, Faculty of Medicine, Dicle University, Diyarbakır, Türkiye
2Department of Cardiology, Mardin Training and Research Hospital, Mardin, Türkiye
3Department of Cardiology, Diyarlife Hospital, Diyarbakır, Türkiye
4Department of Cardiology, Ergani State Hospital, Diyarbakır, Türkiye
5Department of Cardiology, Faculty of Medicine, Dicle University, Diyarbakır, Türkiye
Anatol J Cardiol 2023; 27(1): 56-58 PubMed ID: 36680451 PMCID: 9893712 DOI: 10.14744/AnatolJCardiol.2022.2335